How many tumor suppressor genes are involved in human lung carcinogenesis?

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1403-1410

  Kohno, Takashi ^a   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CHROMOSOME FRAGILE SITE; DNA METHYLATION; GENE DELETION; GENETIC SUSCEPTIBILITY; LUNG CARCINOGENESIS; MICROSATELLITE INSTABILITY; NOTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MICE; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; PROTEINS;

EID: 0032868289     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1403     Document Type: Note

References (123)

1. Haber, D. and Harlow, E. (1997) Tumour-suppressor genes: evolving definitions in the genomic age. Nature Genet., 16, 320-322.
2. Fearon, E.R. (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science, 278, 1043-1050.
3. Pass, H.I., Mitchel, J.B., Johnson, D.H. and Turrisi, A.T. (1996) Lung Cancer. Principles and Practice. Lippincott-Raven Publishers, Philadelphia, PA.
4. Testa, J.R., Liu, Z., Feder, M., Bell, D.W., Balsara, B., Cheng, J.Q. and Taguchi, T. (1997) Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet. Cytogenet., 95, 20-32.
5. Mertens, F., Johansson, B., Hoglund, M. and Mitelman, F. (1997) Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res., 57, 2765-2780.
6. Mori, N., Yokota, J., Oshimura, M., Cavenee, W.K., Mizoguchi, H., Noguchi, M., Shimosato, Y., Sugimura, T. and Terada, M. (1989) Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma. Cancer Res., 49, 5130-5135.
7. Varella-Garcia, M., Gemmill, R.M., Rabenhorst, S.H., Lotto, A., Drabkin, H.A., Archer, P.A. and Franklin, W.A. (1998) Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res., 58, 4701-4707.
8. Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649.
9. Yokota, J., Wada, M., Shimosato, Y., Terada, M. and Sugimura, T. (1987) Loss of heterozygosity on chromosomes 3, 13 and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA, 84, 9252-9256.
10. Shiseki, M., Kohno, T., Adachi, J., Okazaki, T., Otsuka, T., Mizoguchi, H., Noguchi, M., Hirohashi, S. and Yokota, J. (1997) Comparative allelotype of early and advanced stage non-small cell lung carcinomas. Genes Chromosomes Cancer, 17, 71-77.
11. Kawanishi, M., Kohno, T., Otsuka, T., Adachi, J., Sone, S., Noguchi, M., Hirohashi, S. and Yokota, J. (1997) Allelotype and replication error phenotype of small cell lung carcinoma. Carcinogenesis, 18, 2057-2062.
12. Virmani, A.K., Fong, K.M., Kodagoda, D., McIntire, D., Hung, J., Tonk, V., Minna, J.D. and Gazdar, A.F. (1998) Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer, 21, 308-319.
13. Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H. and Yokota, J. (1994) Frequent allelic losses on chromosomes 2q, 18q and 22q in advanced non-small cell lung carcinoma. Cancer Res., 54, 5643-5648.
14. Kohno, T., Kawanishi, M., Matsuda, S., Ichikawa, H., Takada, M., Ohki, M., Yamamoto, T. and Yokota, J. (1998) Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma. Genes Chromosomes Cancer, 21, 236-243.
15. Tsuchiya, E., Nakamura, Y., Weng, S.Y., Nakagawa, K., Tsuchiya, S., Sugano, H. and Kitagawa, T. (1992) Allelotype of non-small cell lung carcinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52, 2478-2481.
16. Sato, S., Nakamura, Y. and Tsuchiya, E. (1994) Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res., 54, 5652-5655.
17. Harbour, J.W., Lai, S.-L., Whang-Peng, J., Gazdar, A.F., Minna, J.D. and Kaye, F.J. (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science, 241, 353-357.
18. Takahashi, T., Nau, M.M., Chiba, I., Birrer, M.J., Rosenberg, R.K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A.F. and Minna, J.D. (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494.
19. Mori, N., Yokota, J., Akiyama, T., Sameshima, Y., Okamoto, A., Mizoguchi, H., Toyoshima, K., Sugimura,T. and Terada, M. (1990) Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene, 5, 1713-1717.
20. Sameshima, Y., Matsuno, Y., Hirohashi, S., Shimosato, Y., Mizoguchi, H., Sugimura, T., Terada, M. and Yokota, J. (1992) Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene, 7, 451-457.
21. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V. and Stockert, E., Day, R.S.III, Johnson, B.E. and Skolnik, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
22. INK4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451.
23. Kirsch, D.G. and Kastan, M.B. (1998) Tumor-suppressor p53: implications for tumor development and prognosis. J. Clin. Oncol. 16, 3158-3168.
24. Havre, P.A., Yuan, J., Hedrick, L., Cho, K.R. and Glazer, P.M. (1995) p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res., 55, 4420-4424.
25. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. and Vande Woude, G.F. (1996) Abnormal centrosome amplification in the absence of p53. Science, 271, 1744-1747.
26. Bertrand, P., Rouillard, D., Boulet, A., Levalois, C., Soussi, T. and Lopez, B.S. (1997) Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene, 14, 1117-1122.
27. Sundaresan, V., Ganly, P., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N.M. and Rabbitts, P. (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene, 1, 1989-1997.
28. Bennett, W.P., Colby, T.V., Travis, W.D. et al. (1993) p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res., 53, 4817-4822.
29. Li, Z.H., Zheng, J., Weiss, L.M. and Shibata, D. (1994) c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am. J. Pathol., 144, 303-309.
30. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T. and Takahashi, T. (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58, 1380-1383.
31. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M. and Ikawa, S. (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature Med., 4, 839-843.
32. Tani, M., Shimizu, K., Kawahara, C., Kohno, T., Ishimoto, O., Ikawa, S. and Yokota, J. (1999) Mutation and expression of the p51 gene in human lung cancer. Neoplasia, in press.
33. Taya, Y. (1997) RB kinases and RB-binding proteins: new points of view. Trends Biochem. Sci., 22, 14-17.
34. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9, 3375-3378.
35. Kelley, M.J., Nakagawa, K., Steinberg, S.M., Mulshine, J.L., Kamb, A. and Johnson, B.E. (1995) Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J. Natl Cancer Inst., 17, 756-761.
36. Hamada, K., Kohno, T., Kawanishi, M., Ohwada, S. and Yokota, J. (1998) Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma. Genes Chromosomes Cancer, 22, 232-240.
37. Miller, C.W., Yeon, C., Aslo, A., Mendoza, S., Aytac, U. and Koeffler, H.P. (1997) The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma. Oncogene, 15, 231-235.
38. Gemma, A., Takenoshita, S., Hagiwara, K., Okamoto, A., Spillare, E.A., McMemamin, M.G., Hussain, S.P., Forreste, K., Zariwala, M., Xiong, Y. and Harris, C.C. (1996) Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines. Int. J. Cancer, 68, 605-611.
39. Shiohara, M., el-Deiry, W.S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D.L., Vogelstein, B. and Koeffler, H.P. (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood, 84, 37815-3784.
40. Kawamata, N., Morosetti, R., Miller, C.W. et al. (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269.
41. Kondo, M., Matsuoka, S., Uchid, K., Osada, H., Nagatake, M., Takagi, K., Harper, J.W., Takahashi, T., Elledge, S.J. and Takahashi, T. (1996) Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene, 12, 1365-1368.
42. Helin, K., Holm, K., Niebuhr, A., Eiberg, H., Tommerup, N., Hougaard, S., Poulsen, H.S., Spang-Thomsen, M. and Norgaard, P. (1997) Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc. Natl Acad. Sci. USA, 94, 6933-6938.
43. Gazzeri, S., Della, V.V., Chaussade, L., Brambilla, C., Larsen, C.J. and Brambilla, E. (1998) The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer. Cancer Res., 58, 3926-3931.
44. Vonlanthen, S., Heighway, J., Tschan, M.P., Borner, M.M., Altermatt, H.J., Kappeler, A., Tobler, A., Fey, M.F., Thatcher, N., Yarbrough, W.G. and Betticher, D.C. (1998) Expression of p16INK4a/p16alpha and p19ARF/ p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene, 17, 2779-2785.
45. Duff, E.K. and Clarke, A.R. (1998) Smad4 (DPC4) - a potent tumor suppressor? Br. J. Cancer, 78, 1615-1619.
46. Norgaar, M., Spang-Thomsen, M. and Poulsen, H.S. (1996) Expression and autoregulation of transforming growth factor ßreceptor mRNA in small cell lung carcinoma cell lines. Br. J. Cancer, 73, 1037-1043.
47. Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T. and Takahashi, T. (1996) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56, 2718-2720.
48. Uchida, K., Nagatake, M., Osada, H., Yatabe, Y., Kondo, M., Mitsudomi, T., Masuda, A., Takahashi, T. and Takahashi, T. (1996) Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res., 56, 5583-5585.
49. Takenoshita, S., Hagiwara, K., Gemma, A., Nagashima, M., Ryberg, D., Lindstedt, B.A., Bennett, W.P., Haugen, A. and Harris, C.C. (1997) Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles. Carcinogenesis, 18, 1427-1429.
50. Tani, M., Takenoshita, S., Kohno, T., Hagiwara, K., Nagamachi, Y., Harris, C.C. and Yokota, J. (1997) Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions. Carcinogenesis, 18, 1119-1121.
51. Riggins, G.J., Kinzler, K.W., Vogelstein, B. and Thiagalingam, S. (1997) Frequency of Smad gene mutations in human cancers. Cancer Res., 57, 2578-2580.
52. Gemma, A., Hagiwara, K., Vincent, F., Ke, Y., Hancock, A.R., Nagashima, M., Bennett, W.P. and Harris, C.C. (1998) hSmad5 gene, a human hSmad family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors. Oncogene, 16, 951-956.
53. Forgacs, E., Biesterveld, E.J., Sekido, Y., Fong, K., Muneer, S., Wistuba, I.I., Milchgrub, S., Brezinschek, R., Virmani, A., Gazdar, A.F. and Minna, J.D. (1998) Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene, 17, 1557-1565.
54. Kohno, T., Takahashi, M., Manda, R. and Yokota, J. (1998) Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer, 22, 152-156.
55. Wang, S.S., Esplin, E.D., Li, J.L., Huang, L., Gazdar, A., Minna, J. and Evans, G.A. (1998) Alterations of the PPP2R1B gene in human lung and colon cancer. Science, 282, 284-287.
56. Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Nagase, H., Ando, H., Yanagisawa, A., Tsuchiya, E., Kato, Y. and Nakamura, Y. (1992) Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res., 52, 6696-6698.
57. Sekido, Y., Bader, S., Latif, F., Gnarra, J.R., Gazdar, A.F., Linehan, W.M., Zbar, B., Lerman, M.I. and Minna, J.D. (1994) Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene, 9, 1599-1604.
58. Sekido, Y., Pass, H.I., Bader, S., Mew, D.J.Y., Christman, M.F., Gazdar, A.F. and Minna, J.D. (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res., 55, 1227-1231.
59. Suzuki, K., Daigo, Y., Fukuda, S., Tokino, T., Isomura, M., Isono, K., Wainwright, B. and Nakamura, Y. (1997) No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung. Jpn J. Cancer Res., 88, 225-228.
60. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. and Issa, J.P. (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196.
61. Jones, P.A. and Laird, P.W. (1999) Cancer epigenetics comes of age. Nature Genet., 21, 163-167.
62. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
63. Gazzeri, S., Gouyer, Y., Vour'ch, C., Brambilla, C. and Brambilla, E. (1998) Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene, 16, 497-504.
64. Makos, M., Nelkin, B.D., Lerman, M.I., Latif, F., Zbar, B. and Baylin, S.B. (1992) Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl Acad. Sci. USA, 89, 1929-1933.
65. Nagatake, M., Osada, H., Kondo, M., Uchida, K., Nishio, M., Shimokata, K., Takahashi, T. and Takahashi, T. (1996) Aberrant hypermethylation at the bc1-2 locus at 18q21 in human lung cancers. Cancer Res., 56, 1886-1891.
66. Eguchi, K., Kanai, Y., Kobayashi, K. and Hirohashi, S. (1997) DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res., 57, 4913-4915.
67. Kohno, T., Kawanishi, M., Inazawa, J. and Yokota, J. (1998) Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method. Hum. Genet., 102, 258-264.
68. Issa, J.P., Ottaviano, Y.L., Celano, P., Hamilton, S.R., Davidson, N.E. and Baylin, S.B. (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet., 7, 536-540.
69. Li, Q., Jedlicka, A., Ahuja, N., Gibbons, M.C., Baylin, S.B., Burger, P.C. and Issa, J.P. (1998) Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene, 16, 3197-3202.
70. Makos, M., Nelkin, B.D., Reiter, R.E., Gnarra, J.R., Brooks, J., Isaacs, W., Linehan, M. and Baylin, S.B. (1993) Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res., 53, 2719-2722.
71. Costello, J.F., Berger, M.S., Huang, H.S. and Cavenee, W.K. (1996) Silencing of p16/CDKN2 expresssion in human gliomas by methylation and chromatin condensation. Cancer Res., 56, 2405-2410.
72. Ohta, M., Inoue, H., Cotticelli, M.G. et al. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84, 587-597.
73. Smith, D.I., Huang, H. and Wang, L. (1998) Common fragile sites and cancer. Int. J. Oncol., 12, 187-196.
74. Sozzi, G., Tornielli, S., Tagliabue, E. et al. (1997) Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res., 57, 5207-5212.
75. Sozzi, G., Pastorino, U., Moiraghi, L., Tagliabue, E., Pezzella, F., Ghirelli, C., Tornielli, S., Sard, L., Huebner, K., Pierotti, M.A., Croce, C.M. and Pilotti, S. (1998) Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res., 58, 5032-5037.
76. Tomizawa, Y., Nakajima, J., Kohno, T., Saito, R., Yamaguchi, N. and Yokota, J. (1998) Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma. Cancer Res., 58, 5478-5483.
77. Le Beau, M.M., Drabkin, H., Glover, T.W., Gemmill, R., Rassool, F.V., McKeithan, T.W. and Smith, D.I. (1998) An FHIT tumor suppressor gene? Genes Chromosomes Cancer, 21, 281-289.
78. McDuffie, H.H. (1991) Clustering of cancer in families of patients with primary lung cancer. J Clin. Epidemiol, 44, 69-76.
79. Tomizawa, Y., Adachi, J., Kohno, T., Yamaguchi, N., Saito, R. and Yokota, J. (1998) Identification and characterization of families with aggregation of lung cancer. Jpn J. Clin. Oncol., 28, 192-195.
80. Sugimura, H., Hamada, G.S., Suzuki, I., Iwase, T., Kiyokawa, E., Kino, I. and Tsugane, S. (1995) CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil. Pharmacogenetics, 5, S145-S148.
81. Wei, Q. and Spitz, M.R. (1997) The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev. 16, 295-307.
82. Perera, F.P. (1997) Environment and cancer: Who are susceptible? Science, 278, 1068-1073.
83. Kohno, T., Shinmura, K., Tosaka, M., Tani, M., Kim, S.R., Sugimura, H., Nohmi, T., Kasai, H. and Yokota, J. (1998) Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene, 16, 3219-3225.
84. Mohrenweiser, H.W. and Jones, I.M. (1998) Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat. Res., 400, 15-24.
85. Pataer, A., Nishimura, M., Kamoto, T., Ichioka, K., Sato, M. and Hiai, H. (1997) Genetic resistance to urethan-induced pulmonary adenomas in SMXA recombinant inbred mouse strains. Cancer Res., 57, 2904-2908.
86. Festing, M.F., Lin, L., Devereux, T.R., Gao, F., Yang, A., Anna, C.H., White, C.M., Malkinson, A.M. and You, M. (1998) At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/JXBALB/c mice. Genomics, 53, 129-136.
87. Dutrillaux, B. (1995) Pathways of chromosome alteration in human epithelial cancers. Adv. Cancer Res., 65, 59-82.
88. Perucho, M. (1996) Cancer of the microsatellite mutator phenotype. J. Biol. Chem., 377, 675-684.
89. Boland, C.R., Sato, J., Saito, K., Carethers, J.M., Marra, G., Laghi, L. and Chauhan, D.P. (1998) Genetic instability and chromosomal aberrations in colorectal cancer: a review of the current models. Cancer Detect. Prev., 22, 377-382.
90. Arzimanoglou, I.I., Gilbert, F. and Barber, H.R. (1998) Microsatellite instability in human solid tumors. Cancer, 82, 1808-1820.
91. Adachi, J., Shiseki, M., Okazaki, T., Ishimaru, G., Noguchi, M., Hirohashi, S. and Yokota, J. (1995) Microsatellite instability in primary and metastatic lung carcinomas. Genes Chromosomes Cancer, 14, 301-306.
92. Peltomaki, P., Lothe, R.A., Aaltonen, L.A. et al. (1993) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res., 53, 5853-5855.
93. Abe, T., Ouyang, H., Migita, T., Kalo, Y., Kimura, M., Shiiba, K., Sunamura, M., Matsuno, S. and Horii, A. (1996) The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability. Eur. J. Surg. OncoL, 22, 474-477.
94. Krajinovic, M., Richer, C., Gorska-Flipot, I., Gaboury, L., Novakovic, I., Labuda, D. and Sinnett, D. (1998) Genomic loci susceptible to replication errors in cancer cells. Br. J. Cancer, 78, 981-985.
95. Fero, M.L., Randel, E., Gurley, K.E., Roberts, J.M. and Kemp, C.J. (1998) The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature, 396, 177-180.
96. Barlow, C., Eckhaus, M.A., Schaffer, A.A. and Wynshaw-Boris, A. (1999) Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nature Genet., 21, 359-360.
97. Marra, M.A., Hillier, L. and Waterston, R.H. (1998) Expressed sequence tags - ESTablishing bridges between genomes. Trends Genet., 14, 4-7.
98. The Sanger Centre and the Washington University Genome Sequence Center (1998) Toward a complete human genome sequence. Genome Res., 8, 1097-1108.
99. Collins, F.S., Brooks, L.D. and Chakravarti, A. (1998) A DNA polymorphism discovery resource for research on human genetic variation. Genome Res., 8, 1229-1231.
100. Gasparian, A.V., Laktionov, K.K., Belialova, M.S., Pirogova, N.A., Tatosyan, A.G. and Zborovskaya, I.B. (1998) Allelic imbalance and instability of microsatellite loci on chromosome 1p in human non-small-cell lung cancer. Br. J. Cancer, 77, 1604-1611.
101. Kohno, T., Otsuka, T., Takano, H., Yamamoto, T., Hamaguchi, M., Terada, M. and Yokota, J. (1995) Identification of a novel phospholipase C family gene at chromosome 2q33 that is homozygously deleted in human small cell lung carcinoma. Hum. Mol. Genet., 4, 667-674.
102. Sundaresan, V., Chung, G., Heppell-Parton, A. et al. (1998) Homozygous deletions at 3p12 in breast and lung cancer. Oncogene, 17, 1723-1729.
103. Boldog, F., Gemmill, R.M., West, J. et al. (1997) Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet., 6, 193-203.
104. Ishikawa, S., Kai, M., Tamari, M., Takei, Y., Takeuchi, K., Bandou, H., Yamane, Y., Ogawa, M. and Nakamura, Y. (1997) Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3 that is homozygously deleted in a lung carcinoma cell line. DNA Res., 4, 35-43.
105. Sekido, Y., Ahmadian, M., Wistuba, I.I., Latif, F., Bader, S., Wei, M.H., Duh, F.M., Gazdar, A.F., Lerman, M.I. and Minna, J.D. (1998) Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene, 16, 3151-3157.
106. Jensen, D.E., Proctor, M., Marquis, S.T. et al. (1998) BAP1; a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene, 16, 1097-1112.
107. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., Nakamura, Y. and Takahashi, T. (1992) Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7, 445-449.
108. Shivapurkar, N., Virmani, A.K., Wistuba, I.I., Milchgrub, S., Mackay, B., Minna, J.D. and Gazdar, A.F. (1999) Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin. Cancer Res., 5, 17-23.
109. Wieland, I., Bohm, M., Arden K.C., Ammermuller, T., Bogatz, S., Viars, C.S. and Rajewsky, M.F. (1996) Allelic deletion mapping on chromosome 5 in human carcinomas. Oncogene, 12, 97-102.
110. Ueno, K., Kumagai, T., Kijima, T., Kishimoto, T. and Hosoe, S. (1998) Cloning and tissue expression of cDNAs from chromosome 5q21-22 which is frequently deleted in advanced lung cancer. Hum. Genet., 102, 63-68.
111. Oyama, T., Kanai, Y., Ochiai, A. et al. (1994) A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res., 54, 6282-6287.
112. Hosoe, S., Ueno, K., Shigedo, Y., Tachibana, I., Osaki, T., Kumagai, T., Tanio, Y., Kawase, I., Nakamura, Y. and Kishimoto, T. (1994) A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res., 54, 1787-1790.
113. Fujiwara, Y., Ohata, H., Kuroki, T., Koyama, K., Tsuchiya, E., Monden, M., Mori, T. and Nakamura, Y. (1995) Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogens, 10, 891-895.
114. Kim, S.K., Ro, J.Y., Kemp, B.L., Lee, J.S., Kwon, T.J., Hong, W.K. and Mao, L. (1998) Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer. Oncogene, 17, 1749-1753.
115. Bepler, G. and Garcia-Blanco, M.A. (1994) Three tumor-suppressor regions on chromosome lip identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc. Natl Acad. Sci. USA, 91, 5513-5517.
116. Schwienbacher, C., Sabbioni, S., Campi, M. et al. (1998) Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples. Proc. Natl Acad. Sci. USA, 95, 3873-3878.
117. Takeuchi, S., Mori, N., Koike, M., Slater, J., Park, S., Miller, C.W., Miyoshi, I. and Koeffler, H.P. (1996) Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res., 56, 738-740.
118. Tamura, K., Zhang, X., Murakami, Y., Hirohashi, S., Xu, H.J., Hu.S.X., Benedict, W.F. and Sekiya,T. (1997) Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int. J. Cancer, 74, 45-49.
119. Abujiang, P., Mori, T.J., Takahashi, T., Tanaka, F., Kasyu, I., Hitomi, S. and Hiai, H. (1998) Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene, 17, 3029-3033.
120. Sato, M., Mori, Y., Sakurada, A., Fukushige, S., Ishikawa,Y., Tsuchiya, E., Saito, Y., Nukiwa, T., Fujimura, S. and Horii, A. (1998) Identification of a 910-kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer. Genes Chromosomes Cancer, 22, 1-8.
121. Konishi, H., Takahashi, T., Kozaki, K., Yatabe, Y., Mitsudomi, T., Fujii, Y., Sugiura, J., Matsuda, H., Takahashi, T. and Takahashi, T. (1998) Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene, 17, 2095-2100.
122. Tran, Y., Benbatoul, K., Gorse, K., Rempel, S., Futreal, A., Green, M. and Newsham,I. (1998) Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene, 17, 3499-3505.
123. Takei, K., Kohno, T., Hamada, K., Takita, J., Noguchi, M., Matsuno, Y., Hirohashi, S., Uezato, H. and Yokota, J. (1998) Novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. Cancer Res., 58, 3700-3705.